
Ottawa bans arthritis drug Bextra CBC \|\| December 19, 2005 The federal government has banned a popular arthritis drug because it may cause a heart attack or stroke. Sales of Bextra have been suspended since last April when the federal government approached its maker, Pfizer Inc., after concerns were raised in the United States and Europe about its possible side effects. The drug, which racked up global sales of $1.3 billion in 2004, has now been banned permanently. "The decision to stop the sale of Bextra is based on information submitted by the manufacturer, Pfizer Canada Inc.," Ottawa said in an announcement late Friday afternoon. "Health Canada concluded that there is insufficient evidence to establish the safety of the drug for its recommended use." Article Posted at www.KnowledgeDrivenRevolution.com A Pfizer spokesman was unavailable for comment. Health Canada started a review of Bextra and related drugs following Merck & Co. Inc.'s withdrawal of a similar drug, Vioxx, in September 2004. Bextra was suspended in April across Canada, the United States and Europe after regulators voiced concerns over cardiovascular risks. Vioxx remains suspended, but the federal government said in July that it would be allowed back on the market if requested. About KDR \| \| Home \| \| Weekly Features Archive	Weekly Weekly Features Archive
In Depth The Number 1 Reason YOU became a Slave Knowledge Driven Look at Your Favorite Canadian Political Parties
Archive October November December 2005 27 28 29 30 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Weekly Features

Ottawa bans arthritis drug Bextra

CBC || December 19, 2005

The federal government has banned a popular arthritis drug because it may cause a heart attack or stroke.

Sales of Bextra have been suspended since last April when the federal government approached its maker, Pfizer Inc., after concerns were raised in the United States and Europe about its possible side effects.

The drug, which racked up global sales of $1.3 billion in 2004, has now been banned permanently.

"The decision to stop the sale of Bextra is based on information submitted by the manufacturer, Pfizer Canada Inc.," Ottawa said in an announcement late Friday afternoon. "Health Canada concluded that there is insufficient evidence to establish the safety of the drug for its recommended use."

Article Posted at www.KnowledgeDrivenRevolution.com

A Pfizer spokesman was unavailable for comment.

Health Canada started a review of Bextra and related drugs following Merck & Co. Inc.'s withdrawal of a similar drug, Vioxx, in September 2004. Bextra was suspended in April across Canada, the United States and Europe after regulators voiced concerns over cardiovascular risks.

Vioxx remains suspended, but the federal government said in July that it would be allowed back on the market if requested.

About KDR | | Home | | Weekly Features Archive

Weekly

Chicken Little Terrorist: Creating Fake Terrorists

Weekly Features Archive

In Depth

The Number 1 Reason YOU became a Slave

Knowledge Driven Look at Your Favorite Canadian Political Parties